Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
14,931,494
-
Share change
-
-617,580
-
Total reported value
-
$1,332,246,388
-
Put/Call ratio
-
22%
-
Price per share
-
$89.22
-
Number of holders
-
183
-
Value change
-
-$60,732,119
-
Number of buys
-
74
-
Number of sells
-
95
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q2 2022
As of 30 Jun 2022 LIGAND PHARMACEUTICALS INC - Common Stock (LGND) had 183 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 14,931,494 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, STATE STREET CORP, MACQUARIE GROUP LTD, VILLERE ST DENIS J & CO LLC, Stephens Investment Management Group LLC, Chicago Capital, LLC, DIMENSIONAL FUND ADVISORS LP, and abrdn plc.
This table shows 183 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.